Predictive Value of Combined Positive Score and Tumor Proportion Score for Immunotherapy Response in Advanced NSCLC

por Ulas, Ezgi B., Hashemi, Sayed M.S., Houda, Ilias, Kaynak, Adem, Veltman, Joris D., Fransen, Marieke F., Radonic, Teodora, Bahce, Idris
Publicado 2023

COX-2 inhibition improves immunotherapy and is associated with decreased numbers of myeloid-derived suppressor cells in mesothelioma. Celecoxib influences MDSC function

por Veltman, Joris D, Lambers, Margaretha EH, van Nimwegen, Menno, Hendriks, Rudi W, Hoogsteden, Henk C, Aerts, Joachim GJV, Hegmans, Joost PJJ
Publicado 2010

Comparison of Myelotoxicity and Nephrotoxicity Between Daily Low-Dose Cisplatin With Concurrent Radiation and Cyclic High-Dose Cisplatin in Non-Small Cell Lung Cancer Patients

por Zazuli, Zulfan, Kos, Renate, Veltman, Joris D., Uyterlinde, Wilma, Longo, Cristina, Baas, Paul, Masereeuw, Rosalinde, Vijverberg, Susanne J. H., Maitland-van der Zee, Anke-Hilse
Publicado 2020

Dynamics of methylated cell-free DNA in the urine of non-small cell lung cancer patients

por Bach, Sander, Wever, Birgit M.M., van de Wiel, Mark A., Veltman, Joris D., Hashemi, Sayed M.S., Kazemier, Geert, Bahce, Idris, Steenbergen, Renske D.M.
Publicado 2021

Low-Dose Cyclophosphamide Synergizes with Dendritic Cell-Based Immunotherapy in Antitumor Activity

por Veltman, Joris D., Lambers, Margaretha E. H., van Nimwegen, Menno, de Jong, Sanne, Hendriks, Rudi W., Hoogsteden, Henk C., Aerts, Joachim G. J. V., Hegmans, Joost P. J. J.
Publicado 2010